Tammy D. Hager, MBA, FABC, Announces Forthcoming Release of The Physician Recruitment Playbook, A Strategic Guide for Building Sustainable...
Globe PR Wire
Today at 2:47pm UTC
Apptunix Strengthens Its Position as a Leading Digital Transformation Partner in the Middle East
Globe PR Wire
Today at 2:41pm UTC
Torvi Set to Disrupt the Global Market with its Sustainable Decentralized Finance in 2026.
Globe PR Wire
Today at 2:15pm UTC
Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics
GlobeNewswire
Today at 12:05pm UTC
The Joint Corp. to Report 2025 Fourth Quarter and Full Year Results on Thursday, March 12 and Host Conference Call and Webcast
GlobeNewswire
Today at 12:05pm UTC
Anika Reports Fourth Quarter and Full Year 2025 Financial Results
GlobeNewswire
Today at 12:05pm UTC
Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights
GlobeNewswire
Today at 12:05pm UTC
Gilat Demonstrates 5G NTN End-to-End Connectivity over GEO Satellite
GlobeNewswire
Today at 12:04pm UTC
Taproot Capital Announces Strategic Partnership with Altair Industries
PR Newswire
Today at 12:03pm UTC
Hamilton Zanze Contributes Ninth Multifamily Asset to the HZ Evergreen Fund
PR Newswire
Today at 12:03pm UTC
The Points Mom Launches The Points Wallet - A Smarter Way to Maximize Credit Cards
PR Newswire
Today at 12:02pm UTC
Carlyle Presents Growth Outlook at 2026 Shareholder Update
GlobeNewswire
Today at 12:01pm UTC
JUNKCO+ Earns 2026 Best Emerging Franchise Award
PR Newswire
Today at 12:01pm UTC
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership
GlobeNewswire
Today at 12:00pm UTC
ST Engineering iDirect's Intuition Ground System to Enhance Connectivity for AiTelecom
PR Newswire
Today at 12:00pm UTC
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
GlobeNewswire
Today at 12:00pm UTC
Toberman Becker Wealth Announces New Team Member: Mike Holtz, CFP®
PR Newswire
Today at 12:00pm UTC
Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics
GlobeNewswire
Today at 12:00pm UTC
DORITOS® LAUNCHES BOLDEST INNOVATION YET: DORITOS PROTEIN
PR Newswire
Today at 12:00pm UTC
Amphista Therapeutics presents new data demonstrating how its advanced Eclipsys® platform is delivering Targeted Glue™ degraders using novel...
GlobeNewswire
Today at 12:00pm UTC